System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Publications

Published Erratum Ahead of print

PubMed: 42507324 DOI: 10.1007/s15010-026-02881-0

Correction: Persistent symptoms and risk factors predicting prolonged time to symptom-free after SARS-CoV-2 infection: an analysis of the baseline examination of the German COVIDOM/NAPKON-POP cohort.

Infection

Authors: Yanyan Shi, Ralf Strobl, Christian Apfelbacher, Thomas Bahmer, Ramsia Geisler, Peter Heuschmann, Anna Schäfer, Hanno Hoven, Thomas Keil, Michael Krawczak, Lilian Krist, Christina Lemhöfer, Wolfgang Lieb, Bettina Lorenz-Depiereux, Rafael Mikolajczyk, Felipe A Montellano, Jens Peter Reese, Stefan Schreiber, Nicole Skoetz, Stefan Störk, Jörg Janne Vehreschild, Martin Witzenrath, Eva Grill

Affiliations

  • Institute for Medical Information Processing, Biometry and Epidemiology (IBE), Faculty of Medicine, Ludwig-Maximilians-Universität München (LMU Munich), Marchioninistr. 15, 81377, Munich, Germany.
  • Pettenkofer School of Public Health, Munich, Germany.
  • German Center for Vertigo and Balance Disorders, University Hospital, Ludwig-Maximilians-Universität München (LMU Munich), Munich, Germany.
  • Institute of Social Medicine and Health Systems Research, Medical Faculty, Otto von Guericke University Magdeburg, Magdeburg, Germany.
  • Internal Medicine Department I, University Hospital Schleswig-Holstein Campus Kiel (UKSH Kiel), Kiel, Germany.
  • Department II of Internal Medicine, Hematology/Oncology, Goethe University, Frankfurt, Frankfurt Am Main, Germany.
  • Institute for Clinical Epidemiology and Biometry, Julius-Maximilians-University, Würzburg, Würzburg, Germany.
  • Clinical Trial Center, University Hospital Würzburg, Würzburg, Germany.
  • Institute for Occupational and Maritime Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • State Institute of Health I, Bavarian Health and Food Safety Authority, Erlangen, Germany.
  • Institute of Medical Informatics and Statistics, Kiel University, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Institute of Physical and Rehabilitation Medicine, University Hospital Jena, Jena, Germany.
  • Institute of Epidemiology, Kiel University, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Research Unit Molecular Epidemiology, Institute of Epidemiology, Helmholtz Center Munich, Munich, Germany.
  • Institute for Medical Epidemiology, Biometrics, and Informatics, Interdisciplinary Center for Health Sciences, Medical Faculty of the Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.
  • German Centre for Mental Health, Site Jena-Magdeburg-Halle, Halle, Germany.
  • Department of Neurology, University Hospital Würzburg, Würzburg, Germany.
  • Evidence-Based Medicine, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Department of Clinical Research and Epidemiology, Comprehensive Heart Failure Center and Department of Internal Medicine I, University Hospital Würzburg, Würzburg, Germany.
  • Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • German Centre for Infection Research (DZIF), Partner Site Bonn‑Cologne, Cologne, Germany.
  • Department of Infectious Diseases, Respiratory Medicine and Critical Care, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • German Center for Lung Research (DZL), Giessen, Germany.
  • Institute for Medical Information Processing, Biometry and Epidemiology (IBE), Faculty of Medicine, Ludwig-Maximilians-Universität München (LMU Munich), Marchioninistr. 15, 81377, Munich, Germany.
  • German Center for Vertigo and Balance Disorders, University Hospital, Ludwig-Maximilians-Universität München (LMU Munich), Munich, Germany.

MeSH

Sars-Cov-2, Signs And Symptoms, Covid-19, Risk Factors, Severe Acute Respiratory Syndrome-Related Coronavirus, Infections